share_log

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K: Current report

Novo Integrated Sciences | 8-K：重大事件
美股SEC公告 ·  03/18 15:35
Moomoo AI 已提取核心信息
Novo Integrated Sciences, Inc. reported on March 18, 2024, that it has entered into an Assignment of Security Purchase Agreement and Promissory Note with RC Consulting Group LLC and RC Consulting Consortium Group LLC. This assignment involves the transfer of all rights and interests in a previously agreed securities purchase agreement and an unsecured 15-year promissory note, originally issued on April 26, 2023, with a principal sum of $70,000,000. The note, which matures on April 26, 2038, includes a yield of 1.52% per annum and contains standard events of default provisions. The company also addressed a prior notification from Nasdaq on February 9, 2024, indicating non-compliance with minimum bid price requirements, which was considered an event of default under the terms of the securities purchase agreement and the note. However, a Limited Waiver was agreed upon with the Holder to exempt any non-compliance related to the minimum bid price requirement. The assignment does not affect the terms of the securities purchase agreement and the note, which remain in full force and effect, except as amended by the waiver.
Novo Integrated Sciences, Inc. reported on March 18, 2024, that it has entered into an Assignment of Security Purchase Agreement and Promissory Note with RC Consulting Group LLC and RC Consulting Consortium Group LLC. This assignment involves the transfer of all rights and interests in a previously agreed securities purchase agreement and an unsecured 15-year promissory note, originally issued on April 26, 2023, with a principal sum of $70,000,000. The note, which matures on April 26, 2038, includes a yield of 1.52% per annum and contains standard events of default provisions. The company also addressed a prior notification from Nasdaq on February 9, 2024, indicating non-compliance with minimum bid price requirements, which was considered an event of default under the terms of the securities purchase agreement and the note. However, a Limited Waiver was agreed upon with the Holder to exempt any non-compliance related to the minimum bid price requirement. The assignment does not affect the terms of the securities purchase agreement and the note, which remain in full force and effect, except as amended by the waiver.
Novo Integrated Sciences, Inc.于2024年3月18日报告称，它已与RC咨询集团有限责任公司和RC咨询联盟集团有限责任公司签订了证券购买协议和期票转让协议。该转让涉及先前商定的证券购买协议和一份最初于2023年4月26日发行的15年期无抵押本票中的所有权利和权益的转让，本金为7000万美元。该票据将于2038年4月26日到期，年收益率为1.52％，并包含违约条款的标准事件。该公司还于2024年2月9日回复了纳斯达克事先发出的通知，该通知表明没有遵守最低出价要求，根据证券购买协议和票据的条款，这被视为违约事件。但是，与持有人商定了有限豁免，以豁免与最低出价要求相关的任何违规行为。该转让不影响证券购买协议和票据的条款，除非经豁免修订，否则这些条款仍然完全有效。
Novo Integrated Sciences, Inc.于2024年3月18日报告称，它已与RC咨询集团有限责任公司和RC咨询联盟集团有限责任公司签订了证券购买协议和期票转让协议。该转让涉及先前商定的证券购买协议和一份最初于2023年4月26日发行的15年期无抵押本票中的所有权利和权益的转让，本金为7000万美元。该票据将于2038年4月26日到期，年收益率为1.52％，并包含违约条款的标准事件。该公司还于2024年2月9日回复了纳斯达克事先发出的通知，该通知表明没有遵守最低出价要求，根据证券购买协议和票据的条款，这被视为违约事件。但是，与持有人商定了有限豁免，以豁免与最低出价要求相关的任何违规行为。该转让不影响证券购买协议和票据的条款，除非经豁免修订，否则这些条款仍然完全有效。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息